Kermode AG - Search Results

1

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.

Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B, Biberacher V, van Pesch V, Sindic C, Bang Oturai A, Søndergaard HB, Sellebjerg F, Jensen PE, Comabella M, Montalban X, Pérez-Boza J, Malhotra S, Lechner-Scott J, Broadley S, Slee M, Taylor B, Kermode AG, Gourraud PA; International Multiple Sclerosis Genetics Consortium; Sawcer SJ, Andreassen BK, Dubois B, Harbo HF. Goris A, et al. Among authors: kermode ag. Brain. 2015 Mar;138(Pt 3):632-43. doi: 10.1093/brain/awu405. Epub 2015 Jan 22. Brain. 2015. PMID: 25616667 Free PMC article.

2

Symptomatic retrochiasmal lesions in multiple sclerosis: clinical features, visual evoked potentials, and magnetic resonance imaging.

Plant GT, Kermode AG, Turano G, Moseley IF, Miller DH, MacManus DG, Halliday AM, McDonald WI. Plant GT, et al. Among authors: kermode ag. Neurology. 1992 Jan;42(1):68-76. doi: 10.1212/wnl.42.1.68. Neurology. 1992. PMID: 1734326

3

Major differences in the dynamics of primary and secondary progressive multiple sclerosis.

Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DP, McDonald WI. Thompson AJ, et al. Among authors: kermode ag. Ann Neurol. 1991 Jan;29(1):53-62. doi: 10.1002/ana.410290111. Ann Neurol. 1991. PMID: 1996879

4

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications.

Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, Rudge P, McDonald WI. Kermode AG, et al. Brain. 1990 Oct;113 ( Pt 5):1477-89. doi: 10.1093/brain/113.5.1477. Brain. 1990. PMID: 2245307

5

Central motor drive and perception of effort during fatigue in multiple sclerosis.

Thickbroom GW, Sacco P, Kermode AG, Archer SA, Byrnes ML, Guilfoyle A, Mastaglia FL. Thickbroom GW, et al. Among authors: kermode ag. J Neurol. 2006 Aug;253(8):1048-53. doi: 10.1007/s00415-006-0159-2. Epub 2006 Apr 10. J Neurol. 2006. PMID: 16607472

6

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.

Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Nat Genet. 2009 Jul;41(7):824-8. doi: 10.1038/ng.396. Epub 2009 Jun 14. Nat Genet. 2009. PMID: 19525955

7

Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.

Wu JS, Qiu W, Castley A, James I, Joseph J, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG. Wu JS, et al. Among authors: kermode ag. J Neurol Sci. 2010 Jan 15;288(1-2):63-7. doi: 10.1016/j.jns.2009.10.005. Epub 2009 Oct 30. J Neurol Sci. 2010. PMID: 19879597

8

HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia.

Wu JS, James I, Qiu W, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG. Wu JS, et al. Among authors: kermode ag. J Neuroimmunol. 2010 Feb 26;219(1-2):109-13. doi: 10.1016/j.jneuroim.2009.11.015. Epub 2009 Dec 16. J Neuroimmunol. 2010. PMID: 20006387

9

The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis.

Gandhi KS, McKay FC, Cox M, Riveros C, Armstrong N, Heard RN, Vucic S, Williams DW, Stankovich J, Brown M, Danoy P, Stewart GJ, Broadley S, Moscato P, Lechner-Scott J, Scott RJ, Booth DR; ANZgene Multiple Sclerosis Genetics Consortium. Gandhi KS, et al. Hum Mol Genet. 2010 Jun 1;19(11):2134-43. doi: 10.1093/hmg/ddq090. Epub 2010 Feb 27. Hum Mol Genet. 2010. PMID: 20190274

10

Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients.

Jensen CJ, Stankovich J, Van der Walt A, Bahlo M, Taylor BV, van der Mei IA, Foote SJ, Kilpatrick TJ, Johnson LJ, Wilkins E, Field J, Danoy P, Brown MA; Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene); Rubio JP, Butzkueven H. Jensen CJ, et al. PLoS One. 2010 Apr 2;5(4):e10003. doi: 10.1371/journal.pone.0010003. PLoS One. 2010. PMID: 20368992 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page